OpenAI is extending its advanced AI capabilities into the realm of biodefense, announcing a new initiative to bolster global biological resilience. The move comes as AI's power in understanding and manipulating biological systems grows exponentially.
The company recently unveiled GPT‑Rosalind, a frontier reasoning model designed to accelerate research in biology and drug discovery. This development, detailed in OpenAI News, showcases the potential of AI to revolutionize healthcare and disease treatment.